Searched for
PARACETAMOL PRICE SURGE
Centre looks to trigger 'Essentials' Act to regulate prices of bulk drugsDrug prices in India: The department of pharmaceuticals (DoP) has been holding meetings with industry executives to take stock of the situa...- Painkiller, antibiotic prices set for marginal increase starting April 1Starting April 1, the prices of essential medicines will experience an increase of 0.6%. This change aligns with the annual alterations in ...
- Rising costs of key chemicals choke production at drug ingredient makersIndia's bulk-drug manufacturers are facing a severe cost crisis as prices of key solvents and intermediates have surged due to supply disru...
- Small pharma companies seek price caps on inputs as costs surgeIndian pharmaceutical units face a severe crisis. Input costs have surged by 200-300 percent. This is due to global conflicts disrupting ra...
- India pharma production hit by propane shortage; vitamin, hormone supply at riskIndia’s pharmaceutical industry is facing the risk of medicine shortages as a propane gas crunch forces several manufacturing units to part...
- Raw nerve: Drugs may get costlier as prices of ingredients surge 30%India's medicine prices are poised for a sharp increase due to a 30% surge in raw material costs, driven by container ship scarcity followi...
- Be patient... prices of your medicines may come down soonIndian medicines may become more affordable as China's active pharmaceutical ingredient (API) prices have dropped significantly, by 35-40%....
- Essential medicines will cost you a bit more from April 1Beginning April 1, prices for essential drugs like painkillers, antibiotics, and anti-diabetic medicines will rise by 1.74%. The increase i...
- IOL Chemicals shares surge 5% as board announces 1:5 stock splitIOL Chemicals share price: IOL Chemicals proposed stock split is subject to shareholder approval via a postal ballot. The record date to de...
- IOL Chemicals announces 1:5 stock split; record date soonIOL Chemicals has approved a 1:5 stock split. This will increase affordability and liquidity. Shareholders will receive 5 new shares for ev...
- Covid & flu: Sales of respiratory, anti-infective drugs shoot up"We have seen a sharp rise in the sales of drugs like paracetamol, analgesics and drugs for respiratory illnesses," said Rajiv Singhal, gen...
- Indians' medical bills set to swell, here's whyThe sharp increase has been witnessed in high-volume key antibiotics including azithromycin and amoxicillin imported from China. "These are...
- Indian companies are paying up to 25 per cent more for China APIsKey APIs have become 12-25% costlier in the past few days amid possible supply disruptions that may squeeze margins and raise drug prices, ...
- Sales of immunity boosters soar amid rise in casesAccording to doctors, as the Covid-19 cases start to increase, people start taking immunity boosters as a precautionary measure, as they se...
- Chemists told to stock up on key medicinesThe National Pharmaceutical Pricing Authority and the Drug Controller General of India held a meeting with AIOCD on Monday regarding the av...
- Pharma companies seek govt nod to hike medicine pricesThe lobby group asked to allow prices of all scheduled formulations to be increased by 10% with immediate effect. Scheduled drugs are those...
- Covid-19: Key drugs, steroids in short supply; input costs surgeTwo anti-virals — Remdesivir and Favipiravir — and Tocilizumab injections being used in the Covid-19 treatment have witnessed massive short...
- India urges China to stabilise price of APIs linked to Covid-19Indian pharmaceutical companies source almost 70% of their requirement of Covid-19-related APIs from China. Demand for Covid-19-related med...
- Stock Ideas: Anand Rathi has a buy call on Granules India, target price Rs 227. The brokerage expects ~25 per cent/~23 per cent revenue/PAT CAGRs over FY20-22.
- Blackstone, KKR, Bain among PE cos in talks to buy Granules IndiaThe investor relations team at Granules India denied the promoters are seeking to sell their stake.
Load More
